PRF Therapy for Pocket Reduction
Comparative Evaluation of Clinical Parameters in Early-Stage III Grade A Periodontitis Patients After Insertion of Platelet Rich Fibrin as Step 2 Phase I Therapy in Periodontal Pockets: A Randomized Clinical Trial
1 other identifier
interventional
13
1 country
2
Brief Summary
Periodontal regenerative therapy has focused on various non-surgical and surgical treatment methods. Platelet-rich fibrin (PRF) has shown to possess multiple uses, including properties that promote healing of both soft and hard tissues. In the present study, we hypothesized that the addition of PRF into periodontal pockets, as an adjunct to conventional scaling and root planing (SRP), would enhance the outcomes of non-surgical periodontal therapy. This split-mouth randomized controlled clinical trial included 26 periodontal pocket sites in 13 patients with periodontitis. The pockets were randomly assigned as either test or control sites. In the test group, PRF was placed as an adjunct to SRP, while the control group received SRP alone. Probing pocket depths (PPD), clinical attachment levels (CAL), gingival recession (GR), plaque index (PI), and gingivitis index (GI) were measured at baseline and at six weeks. The wound healing index was measured during the six-week follow-up period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2022
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2023
CompletedFirst Submitted
Initial submission to the registry
June 8, 2023
CompletedFirst Posted
Study publicly available on registry
June 18, 2023
CompletedJune 18, 2023
June 1, 2023
4 months
June 8, 2023
June 16, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
pocket depth
Probing pocket depths (PPD), clinical attachment levels (CAL), gingival recession (GR), plaque index (PI), and gingivitis index (GI) were measured
6 weeks
Study Arms (2)
patients treated with SRP and insertion of PRF
EXPERIMENTALpatients treated with SRP
ACTIVE COMPARATORInterventions
The pockets were treated with scaling and root planing (SRP) along with the simultaneous insertion of a Platelet Rich Fibrin (PRF) membrane. Blood samples were drawn without anticoagulants in 10 mL tubes, which were immediately centrifuged at 4000 rpm for 8 minutes. Upon centrifugation, the blood showed three distinct layers: the uppermost layer contained platelet poor plasma, the middle layer consisted of a fibrin clot, and the lowermost band appeared bright red due to the presence of red blood cells. The fibrin clot polymerized in a diffuse manner within the tube, which was then cut with sharp scissors and squeezed between two glass slides to obtain a thick membrane. The PRF membrane was carefully handled using a carrier and isolated with a periodontal pack dressing (Coe-Pak). All patients were followed up at one week and six weeks after the treatment.
The pockets were treated using the conventional procedure of scaling and root planing (SRP) utilizing curettes and an ultrasonic device. All patients were followed up at one week and six weeks after the treatment.
Eligibility Criteria
You may qualify if:
- either gender,
- aged 18 years or older,
- patients without a medical history of systemic diseases,
- patient with chronic periodontitis
- patient with 5 or 6 mm of probing depth
You may not qualify if:
- patients with medical history of systemic disease or bleeding disorders
- presence of other gingival diseases (such as leukoplakia, lichen planus, pemphigoid disorders, pemphigus vulgaris, herpetic lesions, Necrotizing Ulcerative Periodontitis (NUP)
- pregnancy
- history of any drug usage affecting the periodontium for the past six months (such as systemic antibiotic therapy)
- previous periodontal treatment in the last six months
- smoking
- teeth with untreated caries
- endodontic lesions and grade II or more mobility
- subjects with acute exacerbation of periodontitis
- patients with systemic
- disease or condition that could affect tissue healing (e.g., autoimmune disease)
- severe furcation involvement (grade II and III)
- abutment for prosthetic rehabilitation
- active orthodontic therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Naples Federico II
Naples, 80123, Italy
Università degli Studi di Napoli Federico II
Napoli, 80131, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor in Dental Sciences, Principal Investigator
Study Record Dates
First Submitted
June 8, 2023
First Posted
June 18, 2023
Study Start
September 15, 2022
Primary Completion
January 15, 2023
Study Completion
February 15, 2023
Last Updated
June 18, 2023
Record last verified: 2023-06